The Breast–Thyroid Cancer Link: A Systematic Review and Meta-analysis

Rates of thyroid cancer in women with a history of breast cancer are higher than expected. Similarly, rates of breast cancer in those with a history of thyroid cancer are increased. Explanations for these associations include detection bias, shared hormonal risk factors, treatment effect, and genetic susceptibility. With increasing numbers of breast and thyroid cancer survivors, clinicians should be particularly cognizant of this association. Here, we perform a systematic review and meta-analysis of the literature utilizing PubMed and Scopus search engines to identify all publications studying the incidence of breast cancer as a secondary malignancy following a diagnosis of thyroid cancer or thyroid cancer following a diagnosis of breast cancer. This demonstrated an increased risk of thyroid cancer as a secondary malignancy following breast cancer [OR = 1.55; 95% confidence interval (CI), 1.44–1.67] and an increased risk of breast cancer as a secondary malignancy following thyroid cancer (OR = 1.18; 95% CI, 1.09–1.26). There is a clear increase in the odds of developing either thyroid or breast cancer as a secondary malignancy after diagnosis with the other. Here, we review this association and current hypothesis as to the cause of this correlation. Cancer Epidemiol Biomarkers Prev; 25(2); 231–8. ©2016 AACR.

[1]  F. Boscoe,et al.  Randomization to Screening for Prostate, Lung, Colorectal and Ovarian Cancers and Thyroid Cancer Incidence in Two Large Cancer Screening Trials , 2014, PloS one.

[2]  C. Eng,et al.  Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations. , 2011, The Journal of clinical endocrinology and metabolism.

[3]  J. Daling,et al.  Multiple primary breast and thyroid cancers: role of age at diagnosis and cancer treatments (United States) , 2000, Cancer Causes & Control.

[4]  Seong-Jang Kim,et al.  Factors associated with the development of new onset diffuse thyroid F18-fluorodeoxyglucose uptake after treatment of breast cancer in patients without a history of thyroid disease or thyroid dysfunction. , 2012, Thyroid : official journal of the American Thyroid Association.

[5]  A. Oshima,et al.  Second Primary Cancers Following Breast Cancer in the Japanese Female Population , 2001, Japanese journal of cancer research : Gann.

[6]  T. Wilt,et al.  Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2011 .

[7]  A. Neugut,et al.  Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers. , 2006, Cancer letters.

[8]  J. Romijn,et al.  The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer. , 2006, European journal of endocrinology.

[9]  Tae Yong Kim,et al.  Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population. , 2013, European journal of endocrinology.

[10]  L. Brinton,et al.  Second cancer following cancer of the breast in Connecticut, 1935-82. , 1985, National Cancer Institute monograph.

[11]  M. V. Folgueras,et al.  Risk factors for second primary tumours in breast cancer survivors , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[12]  C. Lewis,et al.  Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England , 2001, British Journal of Cancer.

[13]  L. Hardell,et al.  External radiotherapy prior to thyroid cancer: a case-control study. , 1993, International Journal of Radiation Oncology, Biology, Physics.

[14]  M H Skolnick,et al.  Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. , 1994, Journal of the National Cancer Institute.

[15]  M. McBride,et al.  Second primary cancers in thyroid cancer patients: a multinational record linkage study. , 2006, The Journal of clinical endocrinology and metabolism.

[16]  A. Ng,et al.  Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors , 2013, Nature Reviews Clinical Oncology.

[17]  Hyeong Sik Ahn,et al.  Korea's thyroid-cancer "epidemic"--screening and overdiagnosis. , 2014, The New England journal of medicine.

[18]  N. Takeichi,et al.  Effects of sex difference, gonadectomy, and estrogen on N-methyl-N-nitrosourea induced rat thyroid tumors. , 1990, Cancer research.

[19]  Amy Y. Chen,et al.  The development of breast carcinoma in women with thyroid carcinoma , 2001, Cancer.

[20]  E. Kaplan,et al.  Radiation-induced thyroid cancer: the Chicago experience. , 2009, Surgery.

[21]  E. Ron,et al.  Multiple primary breast and thyroid cancer. , 1984, British Journal of Cancer.

[22]  C. la Vecchia,et al.  Cancer risk in women with previous breast cancer. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  Herb Chen,et al.  Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. , 2008, The Journal of clinical endocrinology and metabolism.

[24]  M. Pollán,et al.  Risk of second primary cancer among women with breast cancer: a population-based study in Granada (Spain). , 2013, Gynecologic oncology.

[25]  Louise Davies,et al.  Current thyroid cancer trends in the United States. , 2014, JAMA otolaryngology-- head & neck surgery.

[26]  I. Soerjomataram,et al.  Primary Malignancy after Primary Female Breast Cancer in the South of the Netherlands, 1972–2001 , 2005, Breast Cancer Research and Treatment.

[27]  S. Straus,et al.  Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. , 2009, Thyroid : official journal of the American Thyroid Association.

[28]  E. Ron,et al.  Thyroid cancer and multiple primary tumors in the SEER cancer registries 1 , 2005, International journal of cancer.

[29]  C E Land,et al.  Breast cancer risk from low-dose exposures to ionizing radiation: results of parallel analysis of three exposed populations of women. , 1980, Journal of the National Cancer Institute.

[30]  A. McTiernan,et al.  Incidence of thyroid cancer in women in relation to known or suspected risk factors for breast cancer. , 1987, Cancer research.

[31]  E. Babin,et al.  Risk of second primary cancer following differentiated thyroid cancer , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[32]  E. Saxén,et al.  Multiple cancer--an epidemiologic exercise in Finland. , 1985, Journal of the National Cancer Institute.

[33]  C. Moskowitz,et al.  Solid tumor second primary neoplasms: who is at risk, what can we do? , 2013, Seminars in oncology.

[34]  Miao-Fen Chen,et al.  Increased Risk for Second Primary Malignancies in Women with Breast Cancer Diagnosed at Young Age: A Population-Based Study in Taiwan , 2008, Cancer Epidemiology Biomarkers & Prevention.

[35]  C. Edmonds,et al.  The long-term hazards of the treatment of thyroid cancer with radioiodine. , 1986, The British journal of radiology.

[36]  C. Glanzmann.  Subsequent malignancies in patients treated with 131-iodine for thyroid cancer. , 1992, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[37]  Jose M. Silva,et al.  Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer , 2002, Oncogene.

[38]  C. Shapiro,et al.  Second cancers after breast cancer treatment. , 2003, Seminars in oncology.

[39]  Miao-Fen Chen,et al.  Second primary malignancies following thyroid cancer: a population-based study in Taiwan. , 2013, European journal of endocrinology.

[40]  G. De Pergola,et al.  Obesity as a Major Risk Factor for Cancer , 2013, Journal of obesity.

[41]  J. Tward,et al.  The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. , 2008, The Journal of clinical endocrinology and metabolism.

[42]  E. Salazar,et al.  Effects of thyroid hormones on human breast cancer cell proliferation , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[43]  F. Bray,et al.  Risk of Primary Non–Breast Cancer After Female Breast Cancer by Age at Diagnosis , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[44]  M. Auersperg,et al.  Second primary cancers following thyroid cancer in Slovenia. A population-based cohort study. , 1998, European journal of cancer.

[45]  C. Hogue,et al.  Multiple primary tumours in women following breast cancer, 1973–2000 , 2006, British Journal of Cancer.

[46]  M. Papa,et al.  Second primary breast and thyroid cancers (Israel) , 2003, Cancer Causes & Control.

[47]  J. Schenker,et al.  Multiple primary malignant neoplasms in breast cancer patients in Israel , 1984, Cancer.

[48]  Shuangge Ma,et al.  The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas. , 2013, Thyroid : official journal of the American Thyroid Association.

[49]  C. Rubino,et al.  Increased risk of second cancers following breast cancer: Role of the initial treatment , 2000, Breast Cancer Research and Treatment.

[50]  Timothy J Wilt,et al.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.

[51]  T. Hiyama,et al.  Second primary cancers following female breast cancer in Osaka, Japan--a population-based cohort study. , 1987, Japanese journal of clinical oncology.

[52]  J. Olsen,et al.  Risk of second cancer among women with breast cancer , 2006, International journal of cancer.

[53]  M. Schlumberger,et al.  Leukaemias and cancers following iodine-131 administration for thyroid cancer. , 1997, British Journal of Cancer.

[54]  P. Hall,et al.  Cancer risks in thyroid cancer patients. , 1991, British Journal of Cancer.

[55]  C. Eng,et al.  Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53 , 2011, Human molecular genetics.

[56]  J. Shikany,et al.  Obesity and Thyroid Cancer Risk among U.S. Men and Women: A Pooled Analysis of Five Prospective Studies , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[57]  E Cardis,et al.  The Chernobyl accident--an epidemiological perspective. , 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

[58]  F. Consorti,et al.  Nulliparity enhances the risk of second primary malignancy of the breast in a cohort of women treated for thyroid cancer , 2011, World journal of surgical oncology.

[59]  R. Weigel,et al.  Risk of Subsequent Primary Thyroid Cancer after Another Malignancy: Latency Trends in a Population-based Study , 2012, Annals of Surgical Oncology.

[60]  G. Kerr,et al.  Multiple primary tumours in patients treated with radiotherapy for breast cancer. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[61]  P. Hall,et al.  Tumors after radiotherapy for thyroid cancer. A case-control study within a cohort of thyroid cancer patients. , 1992, Acta oncologica.

[62]  Timothy J Wilt,et al.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.

[63]  V. Pompe‐Kirn,et al.  Second primary cancers in breast cancer patients in Slovenia , 1997, Cancer Causes & Control.

[64]  M. Dottorini,et al.  Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[65]  T. Ohnishi,et al.  Expression of the estrogen receptor in human thyroid neoplasms. , 1994, Cancer letters.

[66]  E. Kaplan,et al.  Benign and Malignant Thyroid Incidentalomas Are Rare in Routine Clinical Practice: A Review of 97,908 Imaging Studies , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[67]  F. Vathaire.  The carcinogenic effects of radioiodine therapy for thyroid carcinoma , 2008, Nature Clinical Practice Endocrinology &Metabolism.

[68]  U. Bick,et al.  Breast cancer in young women after treatment for Hodgkin's disease during childhood or adolescence--an observational study with up to 33-year follow-up. , 2014, Deutsches Arzteblatt international.

[69]  A. Gafni,et al.  Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis. , 2007, Thyroid : official journal of the American Thyroid Association.

[70]  K. Hemminki,et al.  Second primary neoplasms after 19281 endocrine gland tumours: aetiological links? , 2001, European journal of cancer.

[71]  E. Negri,et al.  A pooled analysis of case-control studies of thyroid cancer¶ I. Methods , 1999, Cancer Causes & Control.

[72]  W. Mackillop,et al.  Risk of thyroid carcinoma in a female population after radiotherapy for breast carcinoma , 2001, Cancer.

[73]  C. Eng,et al.  Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome. , 2010, JAMA.

[74]  M. Schlumberger,et al.  The risk of multiple primary breast and thyroid carcinomas , 2003, Cancer.

[75]  R. Tiwari,et al.  Metastatic phenotype is regulated by estrogen in thyroid cells. , 2010, Thyroid : official journal of the American Thyroid Association.

[76]  Shuangge Ma,et al.  Diagnostic radiography exposure increases the risk for thyroid microcarcinoma: a population-based case–control study , 2015, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[77]  Fiona Douglas,et al.  Tumor risks and genotype–phenotype–proteotype analysis in 358 patients with germline mutations in SDHB and SDHD , 2010, Human mutation.

[78]  M. Hammami,et al.  Patterns of radioiodine uptake by the lactating breast , 1994, European Journal of Nuclear Medicine.

[79]  G. Matanoski,et al.  Multiple primary neoplasms in patients with salivary gland or thyroid gland tumors , 1986, The Laryngoscope.

[80]  P. Hall,et al.  Second primary malignancies in thyroid cancer patients , 2003, British Journal of Cancer.

[81]  Nathaniel Rothman,et al.  International patterns and trends in thyroid cancer incidence, 1973–2002 , 2009, Cancer Causes & Control.

[82]  J. Olsen,et al.  Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Denmark, 1943-80. , 1985, National Cancer Institute monograph.

[83]  A. Neugut,et al.  Incidences and Trends of Second Cancers in Female Breast Cancer Patients: A Fixed Inception Cohort-based Analysis (United States) , 2006, Cancer Causes & Control.

[84]  B. Asselain,et al.  Second malignancies after breast cancer: the impact of different treatment modalities , 2008, British Journal of Cancer.

[85]  J. Barnholtz-Sloan,et al.  Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[86]  B. Alexander,et al.  Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. , 2010, American journal of epidemiology.

[87]  E. Negri,et al.  A Pooled Analysis of Case–Control Studies of Thyroid Cancer. VI. Fish and Shellfish Consumption , 2001, Cancer Causes & Control.

[88]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[89]  Q. Duh,et al.  Latency Period of Thyroid Neoplasia After Radiation Exposure , 2004, Annals of surgery.

[90]  Brinton La,et al.  Second cancer following cancer of the breast in Connecticut, 1935-82. , 1985 .

[91]  D. Green,et al.  Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[92]  B. Duffy,et al.  Cancer of the thyroid in children: a report of 28 cases. , 1950, The Journal of clinical endocrinology and metabolism.